Skip to content

Author

Xiang-Yu Li

We have 1 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

MSTO1 promotes hepatocellular carcinoma progression and represents a potential target for immunotherapy.

Overall, MSTO1 plays an important role during the development of HCC, and it was also associated with survival or response to immunotherapy, and the progression of HCC may be associated with HSP90AB1 and MYC, and targeting MSTO1 may effectively enhance the efficacy of anti-PD-1 therapy.

Xiang-Dong Li, Hao-Liang Zhu, Min-Hao Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.